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Immunoglobulin Production in Vitro in Major 
Depression: A Pilot Study on the Modulating 
Action of Endogenous Cortisol 
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Herman G.M. Westenberg, and Jan M. van Ree 
To investigate the possible differential sensitiviO' of hydrocortisone (HCO) on immunoglobulin 
(Ig) production in depression i  relation to endogenous cortisol evels, blood was obtained at 8 
AM and 4 PM from 10 inpatients with major depression according to DSM-III-R criteria and 10 
age- and sex-matched healthy subjects. Peripheral blood lymphocytes were cultured in the 
presence of graded concentrations (10-~-10 -SM) of riCO to study the effect on immunoglobulin 
(lgG and IgM) synthesis. In addition, peripheral blood lymphocytes were cultured in the 
presence of pokeweed mitogen (PWM) to study any additional effect of graded concentrations 
of riCO (10-~-10 -~M) on lgG and lgM synthesis. Mean plasma cortisol evels at both time points 
were higher in patients compared to controls. HCO--preferentially atconcentrations of 104- 
10 ~ molar--stimulated IgG and IgM production in controls, except for IgM production in the 8 
AM samples, when the cells were cultured in the absence of PWM. Under these culture 
conditions, HCO stimulated IgG but not IgM synthesis in depressed patients. PWM-driven lgG 
and IgM synthesis in controls was stimulated by HCO in both the 8 AM and the 4 PM samples. In 
patients PWM driven lgG synthesis was stimulated by HCO in the 8 AM but not in the 4 PM 
samples. PWM-stimulated IgM synthesis was not augmented by HCO in depressed patients. We 
conclude that a differential sensitivi O, to the effects of HCO exists in in vitro IgG and IgM 
synthesis between depressed patients and controls. Furthermore, we suggest that immunocom- 
petent cells of depressed patients possess corticosteroid-resistant properties. 
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Introduction 
The modulating action of glucocorticoids on the immune 
response is expressed at various levels (Cupps and Fauci 
1982). Glucocorticoids exert inhibiting effects on the ex- 
pression of immune response antigen on the surface, which 
plays a role in the interaction of B cells with T cells (McMil- 
lan et al 1988), on the synthesis of cytokines---e.g., interleu- 
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kin-1 (IL-1), interleukin-2 (II-2), and interleukin-6 (IL-6) 
(Snyder and Unanue 1982; Arya et al 1984; Staruch and 
Wood 1985; Woloski et al 1985; Grabstein et al 1986) and 
on cytokine receptors (Reed et al 1986; Akahoshi et al 
1988). Furthermore, glucocorticoids induce suppression of 
B cell activation and proliferation (Bowen and Fauci 1984; 
Cupps et al 1985) and T cell proliferation (Gillis et al 1979). 
They exhibit a differential effect on the function ofT helper 
and T suppressor cells (Bradley and Mishell 1981). The 
above-described mechanisms of glucocorticoids may be 
integrated in the role glucocorticoids play in modulating the 
effects on immunoglobulin (Ig) synthesis. In the pokeweed 
mitogen (PWM)-~:lriven Ig synthesis by cultured lympho- 
cytes, physiological s well as supraphysiological doses of 
glucocorticoids have an enhancing property, provided that 
they are present at the beginning of the culture (Fauci et al 
1977; Cooper et al 1979; Brieva et al 1983). In addition, Ig 
production can be induced by glucocorticoids in lympho- 
cytes cultured in vitro in the presence of fetal calf serum 
(FCS), without he addition of any other mitogen (Smith et 
al 1972; Grayson et al 1981 ;Orson et al 1983). FCS seems to 
be required for this stimulating effect (Sierakowski and 
Goodwin 1988). Disturbances in hypothalamo-pituitary- 
adrenal (HPA) axis function have been described in affec- 
tive disorders (Carroll et al 1976a,b; Fang et al 1981; Pfohl 
et al 1985; Roy et al 1987; Coppen and Metcalfe 1987; Ball 
et al 1987; Kathol et al 1989). Data on a relationship be- 
tween the hypercortisolemia present in depressed patients 
and disturbances in immune reactivity in vitro are conflict- 
ing. An inverse relationship between mitogenic lymphocy- 
tic response and plasma cortisol in depressed patients has 
been reported by Schleifer et al (1984), whereas others did 
not find an association between immune function and 
plasma cortisol (Kronfol et al 1986; Nerozzi et al 1989). In 
assessing immune reactivity in relation to variances in en- 
dogenous cortisol, we studied the relationship between the 
circadian rhythm of cortisol and the in vitro modulating 
effect of this hormone on in vitro Ig synthesis in depressed 
patients and age- and sex-matched controls. We hypothe- 
sized that the expected higher plasma cortisol levels in 
patients would render in vitro patient lymphocytes tobe less 
sensitive to the effects of hydrocortisone than cells obtained 
from controls. In addition, if the circadian rhythm of the 
HPA axis was to be preserved in patients, we expected to 
find differences in immunoreactivity within groups. 
Materials and Methods 
Subjects 
The protocol was approved by the ethics review committees 
of the Academic Hospital Utrecht and the Academic Hospi- 
tal Rotterdam-Dijkzigt. Patients and controls gave informed 
consent to participate in the study, Ten inpatients uffering 
from unipolar depressive illness participated in this study. 
All patients were given the diagnosis major depressive dis- 
order according to DSM-II1-R criteria (APA 1987). Ten 
sex- and age-matched subjects volunteered as controls in 
this study; they were an unpaid community sample. All 
participants were free from clinical disorders associated 
with immunological terations. The depressed patients had 
not taken psychotropic medication at least 7 days prior to 
entry into the study. One patient used oral contraceptives. 
None of the control subjects used medication, except for one 
on oral contraceptives. 
Blood Sampling 
Heparinized blood samples were taken from every partici- 
pant at 8 AM and at 4 PM by venipuncture, with an interval of 
1-3 days. 
Psvchometrv 
Hamilton depression rating scale (Hamilton 1960) scores of 
all subjects were obtained on the day of the second blood 
sample. 
Corticosteroids 
Hydrocortisone (HCO) was dissolved in 100% ethanol, di- 
luted in RPMI 1640 medium (GIBCO), and added to the 
cultures. 
Isolation of Mononuclear Cells 
Heparinized blood was diluted l:l (vol/vol) with minimal 
essential medium (MEM; GIBCO) supplemented with 
streptomycin 100 I~g/ml and penicillin 100 U/ml. Mononu- 
clear cell suspensions were obtained by Ficoll-hypaque 
(Pharmacia) density centrifugation and were washed twice 
with MEM. The immune function tests were performed in 
unpaired experiments. 
Determination f lg Synthesis 
5 x l0 t peripheral blood lymphocytes (PBL) in a final 
volume of 0.6 ml medium were cultured in duplicate in 
round-bottomed 100 x 16 mm polystyrene tubes in RPMI 
1640 containing 20% FCS (GIBCO), 2 Mm glutamine, 
100 p~g/ml streptomycin, and 100 U/ml penicillin. This will 
be referred to as complete medium. HCO in a final concen- 
tration range from 10-9-10 5 M or an equal amount of com- 
plete medium, to provide for basal immunoglobulin synthe- 
sis, was added to all cultures with or without PWM 
(GIBCO). PWM was dissolved in RPMI 1640 and 20% FCS 
in a final concentration of 20 i.zg/ml. Cells were cultured in 
5% CO2 for 7 and 10 days in the presence or absence of 
PWM, respectively. 
lgG and IgM were measured by an ELISA technique 
(Bloem et al 1984). Briefly, after coating the polyvinyl- 
Immunog lobu l in  P roduct ion  in V i t ro  in Ma jor  Depress ion  BIOL PSYCHIATRY 219 
1995:38:217-226 
chloride culture plates (Titertek) with rabbit antisera gainst 
human IgG (Dako) and IgM (CLB, Amsterdam) superna- 
tants in six different dilutions were incubated, followed by 
incubation with peroxidase-labeled conjugated rabbit anti-  
human antibodies (Dako). Between each incubation period 
the plates were washed three times with PBS containing 
0.05% Tween-20. The culture plates were read by an ELISA 
reader at 492 nm. 
Plasma cortisol levels were assayed by a RIA as de- 
scribed by Thijssen et al (1980). 
Statistics 
T tests were performed to test for the effect of time on basal 
immunoglobulin production in cultures from cells sampled 
at 8 AM and 4 PM. The same statistical method was used to 
test for any difference in Hamilton rating scale scores be- 
tween depressed patients and controls. Analysis of the corti- 
sol data was performed by using univariate analysis of 
variance (ANOVA), with the variables group and time 
included in the model. 
Data on immunoglobulins were log-transformed before 
analysis. In all cultures, a HCO concentration of 10 -5 M 
caused a marked reduction of Ig production, obscuring any 
overall augmenting effect of HCO. Therefore these data 
were ignored in all analyses. A multivariate analysis of 
variance (MANOVA) was performed on the immunoglobu- 
lin production data. Three interaction terms were introduced 
in the analyses of these data. They included group, concen- 
tration, and time, to denote the patient and control group, 
HCO concentration, and time of sampling, respectively. 
In any statistical test a p value of .05 or less was consid- 
ered statistically significant. 
Results 
All results are expressed as the mean _+ SEM. 
Demographics 
Eight female and two male patients participated in the study: 
their ages ranged from 32-62 years ~46.1 -+ 3.2 years). The 
ages of eight female and two male controls ranged from 
32-60 years (46.9 ± 2.9 years). 
Psychometrv 
Mean Hamilton rating scale depression score in patients 
was 26.2 + 1.3 (range, 22-33): the controls rated 1.2 _+ (3.3 
(t= 18.5, df= 18,p < .001 ~. 
Plasma Cortisol Levels 
The mean plasma cortisol evels of patients and controls are 
summarized in Table 1. ANOVA on cortisol data revealed a 
Table 1. Mean Plasma Cortisol Levels" 
Sampling time 
No. of 
Group subjects 8 AM 4 PM 
Patients 10 0.67 -+ 0.04 0.47 + 0.06* 
Controls 10 0.56 -+ 0.04 0.34 _+ 0.03** 
'Concentrations are in ~.mol/1 and given as mean ± SEM. 
*p < .01 and **p < .005 as compared to the 8 AM values. 
significant decrease in plasma cortisol at 4 PM as compared 
to the 8 AM samples in both patients and controls (F(1,9) = 
10.6, p = .01 and F(1,9) = 39.5, p < .0001, respectively). 
The means of plasma cortisol evels at both time points were 
higher in patients (F(i ,18) = 6, p = .03). No time x group 
interaction was observed. 
Basal Immunoglobulin Production in the 
Absence of PWM 
Basal i mmunoglobulin concentrations are given in Table 2; 
a graphic representation is given in Figures 1-4. Within 
groups, the amounts o f lgG and IgM produced at 8 AM and at 
4 PM were similar in patients and controls. Between-group 
comparison revealed no statistically significant differences, 
except for lgG production at 4 PM, which was significantly 
higher in controls in comparison with patients (t = -2.3; df= 
17,p= .03). 
Basal PWM-Driven lmmunoglobulin Production 
Within both the control and the patient group, no significant 
differences were observed between either 8 AM and the 4 PM 
IgG concentrations or between the 8 AM and 4 PM IgM 
concentrations. Both 8 AM and 4 PM patient values were 
approximately twice as high as 8 AM and 4 PM control IgG 
values. These differences were statistically significant 
(8 AM: t = 3; df= 18;p = 0.007 and 4 PM: t = 2.2; df= t8 ;p  = 
0.O4). 
Although mean 8 AM and 4 PM patient IgM values were 
respectively 130% and 155% of control IgM values, no 
significant differences were found between groups at both 
time points. 
HCO-Stimulated Immunoglobulin Synthesis n the 
A bsenc'e of PWM 
The IgG and IgM production in the absence of PWM is 
shown in Figures 1 and 2, respectively. MANOVA revealed 
a significant main HCO concentration effect on IgG and 
IgM production (IgG: F(4,14) = 13.5, p = .0001; IgM: 
F(4,13) = 5.6, p = .007). No interaction was present between 
concentration and time or between concentration a d group, 
nor was a concentration x group x time effect present. HCO 
increased IgG production in 8 AM and in 4 PM samples in 
patients as well as in controls, preferentially at concentra- 
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Table 2. Basal Immunoglobulin Production" 
IgG IgM 
Group 8 AM 4 PM 8 AM 4 PM 
Patients e 1903.3 _+ 405.5 1473.9 ± 246.3* 
Controls ~ 2007.3 + 352.1 2670.6 + 430.9 
Patients' 5314.0 ± 690.0** 7308.8 ± 1445. I *** 
Controls' 2478.0 + 560.3 3615.2 ± 722.8 
1031.0 _+ 294.8 740.6 ± 140.9 
965.7 ± 167.3 1678.7 ± 506.0 
1750.2 ± 565.8 2124.2 ÷ 790.6 
1317.1 ± 482.3 1370.1 ± 460.9 
"Concentrations are in ng/10 ~ cells and given as mean +_ SEM 
~lg production i  cultures without pokeweed mitogen (PWM) 
' PWM-driven lg production. 
*p < .05 as compared to controls. 
**p < ,01 and ***p < .05 as compared to controls 
t ions between 10 -s and 104 molar. A mean signif icant con- 
centrat ion effect was observed in patients (F(4,6) = 8.5, p = 
.01) as well as in controls (F(4,5) = 7.8, p = .02). No t ime × 
concentrat ion interact ion was observed in either group. 
Subsequent  analysis revealed signif icant increments at 8 
AM and at 4 PM in both groups (8 AM patients: F(4,6) = 5.3,p 
= .04; controls: F(4,5) = 9.2, p = .02; 4 eM patients: F(4,6) = 
6.5, p = .02; controls: F(4,5) = 11, p = .01). In the absence of 
PWM,  IgM product ion was not increased in patients, in 
contrast o a mean signif icant concentrat ion effect in con- 
trois (F(4,5) = 5.3, p = .05; t ime x concentrat ion:  NS). 
Subsequent  analysis on the data of  controls revealed an 
increase in the 4 PM samples only (F(4,5) = 6.2, p = .04). 
HCO-Stimulated hnmunoglobulin Synthesis n the 
Presence of PWM 
The effect of HCO on IgG and IgM product ion in the pres- 
ence of PWM is shown in F igures 3 and 4. A signif icant 
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Figure 1. Effect of hydrocortisone 
(HCO) on in vitro IgG production Pe- 
ripheral blood lymphocytes (PBLs) were 
cultured for 10 days in the absence of 
pokeweed mitogen (PWM). Equal vol- 
umes of medium alone or medium con- 
taining HCO in increasing concentra- 
tions (10-9-10 -5 M.) were added to the 
cultures. Data are expressed as mean -4- 
SEM. Upper panel indicates patient 
samples; lower panel indicates control 
samples. HCO, in the concentration 
range of lff9-10 ~ M, significantly in- 
creased IgG synthesis at both time points 
in both patient and control samples. 
Black bars: 8 AM samples; hatched bars: 
4 PM samples. Abscissa: HCO concen- 
tration (molar; x = llY). 
0 -9  -8  - ?  -6  -8  
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Figure 2. Effect of hydrocortisone 
(HCO) on in vitro IgM production. Cul- 
ture conditions were identical as de- 
scribed with reference to Figure 1. HCO, 
in the concentration range of 10 9-10-6 
M, significantly increased IgM synthesis 
in controls in the 4 PM samples only 
(lower panel). IgM synthesis was not in- 
creased in patient samples at either time 
pint (upper panel). Black bars: 8 AM 
samples; hatched bars: 4 PM samples. 
Abscissa: HCO concentration (molar; x 
= 1@). 
0 -9  -8  -7  -6  -5  
main concentration effect was found for the PWM-driven 
immunoglobulin production (IgG: F(4,14) = 14, p < .0001 :
IgM: F(4,14) = 6.6, p = .003). Similar to HCO-stimulated 
immunoglobulin synthesis in the absence of PWM, in this 
culture condition no interactions were observed--be it ei- 
ther between concentration andtime, between concentra- 
tion and group, or between concentration, group and time. 
A mean concentration effect was found on PWM-stimu- 
lated IgG production in patients (F(4,5) = 5.7,p = .04, time x 
concentration: NS). Subsequent analysis revealed that this 
incremental production was mainly due to the effect of r iCO 
in the 8 AM samples (8 AM: F(4,5) = 6.6, p = .03; 4 PM: NS). 
A mean concentration effect (F(4,6) = 11.9, p = .005: con- 
centration x time: NS) as well as incremental responses 
were observed in the PWM-stimulated IgG samples of the 
controls at both time points (8 AM: F(4,6) = 12.8, p = .004; 
4 PN: F(4,6) = 15, p = .003). PWM-stimulated IgM was not 
augmented by HCO in patients, whereas in the controls 
PWM-stimulated IgM production was raised by HCO 
(mean concentration effect: F(4,6) = 5.7, p = .03; concentra- 
tion x time: NS). In both 8 AM and 4 PM samples, an 
incremental response to HCO was observed (8 AN: F(4,6) = 
10.9, p = .006; 4 PM: F(4,6t = 7.5, p = .02). 
As shown in Figures 1 and 3, most prominent effects of 
HCO are found on IgG production. The increments of the 
highest value observed relative to baseline values for IgG 
and IgM production of both patients and controls were 
found in cultures which lacked the presence of PWM. The 
percentages increase relative to baseline for IgG ranged 
from 229%-292%; those for IgM ranged from 165%-203% 
for 8 AM and 4 PM values, respectively. PWM-driven cell 
cultures demonstrated less relative increments in IgG and 
lgM production. The percentages ranged from 147%-198% 
and from 123%-146%, respectively. 
At 10 -5 molar HCO, immunoglobulin production in all 
culture conditions was below basal values. 
Discussion 
In the present report we studied the effect of graded concen- 
trations of HCO on Ig synthesis in vitro in lymphocytes 
from unipolar depressed patients and controls in relation to 
variations in plasma cortisol levels during the day. Compar- 
ison of lgG and IgM production in both culture conditions in 
both patient and control group yields consistent results. 
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Figure 3. Effect of HCO on in vitro IgG 
production peripheral blood lympho- 
cytes (PBLs) were cultured for 7 days in 
the presence of pokeweed mitogen 
(PWM). Equal volumes of medium 
alone or medium containing HCO in in- 
creasing concentrations (10-9-10 -5 M) 
were added to the cultures. HCO, in the 
concentration range of 10-9-10- 6 M, sig- 
nificantly increased IgG synthesis at 
both time points in control samples 
(lower panel), whereas IgG synthesis in 
patient samples was increased in the 8 
AM samples only (upper panel). Black 
bars: 8 AM samples; hatched bars: 4 PM 
samples. Abscissa: HCO concentration 
(molar; x = 10~). 
Patient and control IgG production, cultured either in the 
presence or in the absence of PWM, showed significant 
incremental responses to HCO, whereas HCO did not affect 
IgM production in the patient group. The absence of an 
effect of HCO on patient lymphocytes was observed in both 
culture conditions. This partly confirmed the expected exis- 
tence of an in vitro difference in sensitivity to HCO between 
patient and control ymphocytes. 
Prolonged hypercortisolemia may induce differential 
changes at the level of cytokines. Interleukin (IL)-2 and 
IL-6 play a role in isotype regulation a d differentiation 
(Esser and Radbrnch 1990). Furthermore, isotype switching 
is known to be regulated by soluble cytokines, such as 
IFN-gamma and IL-4 (Bertolini and Benson 1990). Thus, 
the observed ifference in IgM production between controls 
and patients may have been associated with modulatory 
actions of prolonged hypercortisolemia within the patient 
group. Alternatively, hypercortisolemia may have led to 
regulatory changes within Ig producing plasma cells. 
Whenever HCO was effective, a lower dose was required 
to stimulate IgG synthesis in controls as compared to pa- 
tients. At 10 8 molar, an increase in IgG synthesis was 
observed in both culture conditions in controls, whereas 
incremental responses in patients were observed at 10 _7 
molar HCO. These results suggest hat immunocompetent 
cells of depressed patients are apparently less sensitive to 
the modulating effects of HCO. This observation adds to the 
assumption that Ig production is related to in vivo cortisol 
levels. The cells of the group exposed to the highest cortisol 
levels in vivo, i.e., the lymphocytes of the patient group, did 
show the least sensitivity to cortisol ex vivo. As patients 
were hospitalized, whereas the controls were taken from a 
community sample, hospitalization per se may have ac- 
counted for the difference observed. As was shown by 
Schleifer et al (1989) in a large study in major depressive 
disorder, the patient's hospitalization status was related to 
the mitogen response. 
The finding of a lesser sensitivity to HCO in depressed 
patients is congruent with earlier studies on this subject. 
Natural killer cell activity in depressed patients has been 
shown to be less sensitive to the inhibiting effects of gluco- 
corticoids in vitro (Miller et al 1987). In an attempt to relate 
the disturbances concerning the HPA axis observed in de- 
pressed patients to changes in immune function, hypore- 
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Figure 4. Effect of hydrocortisone 
(HCO) on in vitro IgM production. Cul- 
ture conditions were identical as de- 
scribed with reference to Figure 3. HCO, 
in the concentration range of 10-'-10 ~ 
M, significantly increased IgM synthesis 
at both time points in control samples 
(lower panel), whereas IgM synthesis in 
patient samples was not augmented by 
HCO n both the 8 AM and 4 PM samples 
(upper panel). Black bars: 8 AM sam- 
ples; hatched bars: 4 PM samples. Ab- 
scissa: HCO concentration (molar; x = 
10% 
sponsiveness of mitogen-induced lymphocyte proliferation 
to glucocorticoids has been reported (Gormley et al 1985: 
Meltzer et al 1987). This byporesponsiveness was related to 
post-dexamethasone plasma cortisol levels. Studying enu- 
merative and functional measures of the immune system, 
Syv~ilathi et al (1985) reported no differences in the num- 
bers of Ig secreting cells between depressed patients and 
controls. The authors used the plaque-forming cell assay 
and performed basal measures only, which may explain the 
discongruency between their results and ours. In a number 
of studies in depression, changes in T cells, B cells, or T cell 
subsets have been reported, though the results are conflict- 
ing (Schleifer et al 1989: Marazziti et al 1992). Quantative 
changes in the distribution of these parameters could be an 
inherent feature in depression, irrespective of plasma corti- 
sol levels. 
Unexpectedly. within-group comparison did not show a 
difference in Ig production between 8AM and 4 PM samples. 
This result conflicts with the preceding argumentation f a 
putative association of the hypercortisolemia found in pa- 
tients and a reduced sensitivity to HCO. 
Since in both groups the circadian variation of plasma 
cortisol levels appears to have been preserved, as is shown 
in Table I, one would expect o find a different in vitro Ig 
response to HCO at different points in time within both 
groups if endogenous plasma cortisol evels were to play a 
role. Alternatively, the observed difference in immuno- 
globulin production between patients and controls could be 
the result of the combination of a "ceiling" and timing 
effect--the former being the consequence of increased cor- 
tisol levels in depressed patients at both 8 AM and 4 PM; the 
latter being the effect of a cumulative cortisol increase 
which outlasts the circadian changes in cortisol. When HCO 
and PWM are both added to the cultures, it appeared to be 
possible to enhance the response in depressed patients, 
which argues for a "ceiling" effect. In the absence of the 
additional stimulation provided by PWM, the potential in- 
fluence of HCO may be limited by a combined "ceiling" 
and timing effect, i.e., that persistent increases in cumula- 
tive plasma cortisol in patients may have already influenced 
their circulating lymphocytes to such an extent that they 
could not recover between 8 AM and 4 PM. An anologous 
situation is seen in the irreversible inhibiting effects of 
salicylates on platelet cyclooxygenase (Patrone t al 1985). 
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In the 8 AM as well as the 4 PM samples, basal PWM-driven 
IgG production was considerably higher in patients as com- 
pared to controls. An attractive xplanation would be that 
cells exposed to higher in vivo glucocorticoid levels--as is 
the case in depressed patients--are more responsive to 
PWM, since one expects different in vivo levels of cortisol 
to alter the metabolic state of cells. Basal PWM-stimulated 
IgM levels did not differ between patients and controls. 
however, whereas no difference in basal IgG levels were 
observed in the 8 AM and 4 PM cultures despite a significant 
fall in plasma cortisol in depressed patients. This argues 
against he aforementioned hypothesis but argues in favor 
of the influence of an increased cumulative plasma cortisol 
level over 24 hours. If this is what influences basal ympho- 
cyte immunoglobulin production in the absence of PWM, 
and/or this effect is not able to be reversed for 24 hours, then 
once a certain cumulative plasma cortisol level is reached, 
one would not be able to detect differences in basal ympho- 
cyte immunoglobulin production. 
The relevance of the significantly higher basal level of 
IgG found in the 4 PM cell samples of controls cultured in the 
absence of PWM is questionable, since only slight differ- 
ences were present. Rhythmic variations in total T cells, T 
helper, T suppressor, and B cells have been reported in 
healthy subjects (Thomson et al 1980; Abo et al 1981; 
Ritchie et al 1983; Miyawaki et al 1984 and Levi et al 1985, 
1988), whereas the rhythmic variations of monocytes are 
less evident (Thomson et al 1980; Abo et al 1981). Indeed, 
some of these authors reported a relationship between en- 
dogenous cortisol levels and total lymphocytes or subsets 
(Thomson et al 1980; Abo et al 1981; Miyawaki et al 1984). 
Changes in the T helper/T suppressor ratio as a result of a 
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circadian rhythm of subsets of lymphocytes could lead to 
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